PEN Q4 2020 Earnings — Penumbra, Inc. Revenue & Financial Results | Market Cap Arena

PENPenumbra, Inc.

$13B

Q4 2020 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$167M+14.9% YoY

Gross Profit

$94M56.5% margin

Operating Income

-$2M-1.0% margin

Net Income

$4M2.2% margin

EPS (Diluted)

$0.10

QoQ Revenue Growth

+10.5%

Cash Flow

Operating Cash Flow

-$2M

Free Cash Flow

-$6M

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$823M

Total Liabilities

$185M

Stockholders' Equity

$641M

Cash & Equivalents

$70M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$167M	$145M	+14.9%
Gross Profit	$94M	$98M	-3.9%
Operating Income	-$2M	$11M	-116.5%
Net Income	$4M	$10M	-62.3%

Revenue Segments

Peripheral Vascular

$87M52%

Neuro

$80M48%

Geographic Segments

UNITED STATES

$117M100%